Early trials reported it to be generally well tolerated at low doses, but these studies were small and of short duration
Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
Psychiatry Res
The main reason people are interested in BPC-157 is that animal studies suggest it may help the body repair damaged tissue
Systemic : Inflammation regulation, damage repair, and inter-system communication (e.g., brain, gut, muscles, metabolism)
Apex Supplements is one of Trade India's verified and trusted sellers of listed products
